Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
Introduction. Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk. We have further analyzed the role of diabetes and antidiabetic treatments on HCC. Methods. Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC pati...
Saved in:
Main Authors: | Luca Miele, Cristina Bosetti, Federica Turati, Gianlodovico Rapaccini, Antonio Gasbarrini, Carlo La Vecchia, Stefania Boccia, Antonio Grieco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/570356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin versus insulin in gestational diabetes mellitus: a systematic review
by: Giovanna Noronha Berti, et al.
Published: (2025-01-01) -
Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
by: Xuan Du, et al.
Published: (2018-01-01) -
Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial
by: Daizhi Yang, et al.
Published: (2020-01-01) -
Hypofractionated Stereotactic Radiotherapy after Transarterial Chemoembolisation Failure in an Unresectable Hepatocellular Carcinoma: A Case Presentation
by: Francesco Fiorica, et al.
Published: (2013-01-01) -
Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the All of Us Research Program
by: Erik Almazan, et al.
Published: (2025-01-01)